Over the last 50 years, revascularization and pharmacotherapeutic innovations have led to significant reductions in major adverse CV events associated with both acute and chronic coronary diseases. In historic acute MI trials, long-term use of beta-blockers has led to large reductions in major adverse CV events (MACE). These trials laid the foundation for the widespread and often lifelong use of
New research suggests that taking beta-blockers after a heart attack doesn't significantly reduce the risk of a second heart attack for people with normal heart function.
New research suggests that taking beta-blockers after a heart attack doesn't significantly reduce the risk of a second heart attack for people with normal heart function.
In patients who had revascularization after an acute MI and had a preserved EF, long-term beta-blocker use showed no benefit compared with no beta-blockers, in REDUCE-AMI.
Study Challenges Beta Blocker Use After Heart Attack newsmax.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsmax.com Daily Mail and Mail on Sunday newspapers.